Amino acids activate mTOR Complex 1 via Ca2+/CaM signaling to hVps34

被引:348
作者
Gulati, Pawan [1 ]
Gaspers, Lawrence D. [2 ]
Dann, Stephen G. [1 ]
Joaquin, Manel [3 ]
Nobukuni, Takahiro [1 ]
Natt, Francois [4 ]
Kozma, Sara C. [1 ]
Thomas, Andrew P. [2 ]
Thomas, George [1 ]
机构
[1] Univ Cincinnati, Genome Res Inst, Dept Mol Oncogenesis, Cincinnati, OH 45237 USA
[2] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA
[3] Univ Pompeu Fabra, Cell Signaling Unit, E-08003 Barcelona, Spain
[4] Novartis Pharma AG, Novartis Inst BioMed Res, CH-4002 Basel, Switzerland
关键词
D O I
10.1016/j.cmet.2008.03.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
Excess levels of circulating amino acids (AAs) play a causal role in specific human pathologies, including obesity and type 2 diabetes. Moreover, obesity and diabetes are contributing factors in the development of cancer, with recent studies suggesting that this link is mediated in part by AA activation of mammalian target of rapamycin (mTOR) Complex 1. AAs appear to mediate this response through class III phosphatidylinositol 3-kinase (PI3K), or human vacuolar protein sorting 34 (hVps34), rather than through the canonical class I PI3K pathway used by growth factors and hormones. Here we show that AAs induce a rise in intracellular Ca2+ ([Ca2+](i)), which triggers mTOR Complex 1 and hVps34 activation. We demonstrate that the rise in [Ca2+](i) increases the direct binding of Ca2+/calmodulin (CaM) to an evolutionarily conserved motif in hVps34 that is required for lipid kinase activity and increased mTOR Complex 1 signaling. These findings have important implications regarding the basic signaling mechanisms linking metabolic disorders with cancer progression.
引用
收藏
页码:456 / 465
页数:10
相关论文
共 42 条
[1]
Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38 [J].
Bai, Xiaochun ;
Ma, Dongzhu ;
Liu, Anling ;
Shen, Xiaoyun ;
Wang, Qiming J. ;
Liu, Yongjian ;
Jiang, Yu .
SCIENCE, 2007, 318 (5852) :977-980
[2]
hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase [J].
Byfield, MP ;
Murray, JT ;
Backer, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (38) :33076-33082
[3]
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms [J].
Calle, EE ;
Kaaks, R .
NATURE REVIEWS CANCER, 2004, 4 (08) :579-591
[4]
Differential regulation by calcium reveals distinct signaling requirements for the activation of Akt and p70S6k [J].
Conus, NM ;
Hemmings, BA ;
Pearson, RB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (08) :4776-4782
[5]
mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer [J].
Dann, Stephen G. ;
Selvaraj, Anand ;
Thomas, George .
TRENDS IN MOLECULAR MEDICINE, 2007, 13 (06) :252-259
[6]
Economic causes and consequences of obesity [J].
Finkelstein, EA ;
Ruhm, CJ ;
Kosa, KM .
ANNUAL REVIEW OF PUBLIC HEALTH, 2005, 26 :239-257
[7]
Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism [J].
Gingras, AC ;
Gygi, SP ;
Raught, B ;
Polakiewicz, RD ;
Abraham, RT ;
Hoekstra, MF ;
Aebersold, R ;
Sonenberg, N .
GENES & DEVELOPMENT, 1999, 13 (11) :1422-1437
[8]
GORDON PB, 1993, J BIOL CHEM, V268, P26107
[9]
Hall Randy A, 2004, Methods Mol Biol, V261, P167
[10]
Activation of S6K1 (p70 ribosomal protein S6 kinase 1) requires an initial calcium-dependent priming event involving formation of a high-molecular-mass signalling complex [J].
Hannan, KM ;
Thomas, G ;
Pearson, RB .
BIOCHEMICAL JOURNAL, 2003, 370 :469-477